PCSK9 inhibitors reduce cardiovascular events, preliminary data show
- PMID: 25782694
- DOI: 10.1136/bmj.h1508
PCSK9 inhibitors reduce cardiovascular events, preliminary data show
Comment on
-
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.N Engl J Med. 2015 Apr 16;372(16):1500-9. doi: 10.1056/NEJMoa1500858. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773607 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous